DVS Sciences Inc.
http://www.dvssciences.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From DVS Sciences Inc.
Diagnostics In 2014: More Of The Same
In many ways, the year in diagnostics can be characterized as “more of the same.” The biggest newsmaker was FDA’s finally taking steps toward establishing an oversight framework for the regulation of laboratory-developed tests.
Deals In Depth: January 2014
Genzyme made a significant investment in RNA interference in a new deal with Alnylam; J&J sold Ortho-Clinical Diagnostics to Carlyle Group for just over $4 billion; biopharma financing reached $2.8 billion in January, more than doubling December’s total; and device companies only raised money privately only in January, mostly from late-stage venture rounds.
Deals Shaping The Medical Industry, March 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January through February 2014.
Company Information
- Industry
- Research, Analytical Equipment & Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice